Exploring how social acceptance affects substance use in LGBTQ+ youth
Social safety as a novel mechanism of risk for problematic substance use among sexual and gender minority youth
This study looks at how feeling accepted and safe affects substance use among LGBTQ+ youth, aiming to find ways to support them better and reduce their risk of using drugs or alcohol.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11070608 on NIH RePORTER |
What this research studies
This research investigates the relationship between social safety, or feelings of acceptance, and the risk of substance use among sexual and gender minority (SGM) youth. It aims to understand how experiences of discrimination and minority stress contribute to substance use behaviors in this population. By identifying protective factors that enhance social safety, the study seeks to inform the development of targeted interventions and policies that can help reduce substance use risk among SGM youth. The research will involve data collection and analysis to explore these dynamics in depth.
Who could benefit from this research
Good fit: Ideal candidates for participation are sexual and gender minority youth aged 12 to 20 who may be experiencing substance use issues.
Not a fit: Patients who do not identify as sexual or gender minorities may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved support programs that reduce substance use among LGBTQ+ youth.
How similar studies have performed: Previous research has shown that addressing social determinants can effectively reduce substance use risk in various populations, suggesting potential success for this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Haik, Amanda — Univ of North Carolina Chapel Hill
- Study coordinator: Haik, Amanda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.